Back To: Home : Featured Technology : High Throughput Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Invitrogen adopts BellBrook Labsí Transcreener HTS
December 2007
SHARING OPTIONS:

MADISON, Wis.-BellBrook Labs, a provider of high-throughput screening tools for the drug discovery industry, announced that Invitrogen is adopting BellBrook's Transcreener HTS Assay Platform as part of a technology licensing agreement. Introduced in 2005, Transcreener HTS Assay Platform enables incorporation of hundreds of new drug targets into high-throughput screening.
†"We have received a tremendous response from the HTS commmunity since we introduced the concept of ADP immunodetection as a kinase assay method almost two years ago," says Bob Lowery, CEO of BellBrook Labs. "We've achieved enough traction in the market that now is the right time to increase penetration through outlicensing, and Invitrogen has a very strong presence."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.